Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -6.373% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COC(=O)c1c(C)oc(C)c1S(=O)(=O)N1CCCC1
b CCCN1Cc2cccc(C(=O)NC3CCCC3)c2C1=O
c Cc1[nH]nc(N2CCCCC2)c1[N+](=O)[O-]
Answer: c. Cc1[nH]nc(N2CCCCC2)c1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1[nH]nc(N2CCCCC2)c1[N+](=O)[O-]
Cc1[nH]nc(N2CCCCC2)c1[N+](=O)[O-]
(5-methyl-3-piperidin-1-yl-1H-pyrazol-4-yl)-oxido-oxoazanium